GSK, Pfizer RSV Shots Must Warn About Rare Paralysis Risk
20 hours, 54 minutes ago

GSK, Pfizer RSV Shots Must Warn About Rare Paralysis Risk

Live Mint  

-- GSK Plc and Pfizer Inc.’s vaccines for a common respiratory virus must carry warnings that they may be tied to an increased risk of a rare neurological side effect that can lead to paralysis, the US Food and Drug Administration said. A study done after the respiratory syncytial virus shots were approved suggests that people given GSK’s Arexvy and Pfizer’s Abrysvo may be at increased risk of Guillain-Barré syndrome for 42 days following immunization, the agency said in a safety communication issued Tuesday. While the data suggests an increased risk with the vaccines, there isn’t enough evidence to show the shots are causing the condition, the agency said. The potential risk of respiratory syncytial virus shots has been known, with the Center for Disease Control and Prevention’s vaccine advisory panel discussing the danger last year.

Risk Fda Gsk Pfizer Rsv  paralysis  shots  safety  warn  increased  fda  virus  vaccines  gsk  risk  respiratory  pfizer  rsv  syndrome  guillainbarré  rare

History of this topic

Guillain-Barre syndrome 'more common than expected' with RSV vaccine in older people, CDC reiterates
7 months, 1 week ago

Guillain-Barre syndrome 'more common than expected' with RSV vaccine in older people, CDC reiterates

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Reports of a rare nervous …

CDC panel is investigating whether RSV vaccine made by Pfizer is causing rare paralysis condition Guillain-Barre syndrome
10 months, 1 week ago

CDC panel is investigating whether RSV vaccine made by Pfizer is causing rare paralysis condition Guillain-Barre syndrome

Daily Mail  

Health officials are probing a possible link between two new RSV vaccines and cases of a rare nervous system disorder in older adults. The RSV vaccine may be linked to a small increase in the risk of a rare neurological disorder, health officials say Guillain-Barre syndrome is a rare condition in which the immune system starts to damage a person's …

Officials investigate rare nervous system disorder in older adults who got RSV vaccine
10 months, 1 week ago

Officials investigate rare nervous system disorder in older adults who got RSV vaccine

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Health officials are investigating whether …

Largest Covid vaccine study ever finds shots are linked to small increased risk of neurological, blood and heart disorders - but they are still extremely rare
10 months, 2 weeks ago

Largest Covid vaccine study ever finds shots are linked to small increased risk of neurological, blood and heart disorders - but they are still extremely rare

Daily Mail  

Covid vaccines have been linked to small increases in heart, blood, and neurological disorders, according to the largest global study of its kind. There was also a 1.3 to 1.4 times greater risk of having a seizure following the first and second doses of the Moderna vaccine, as well as the fourth dose of the Pfizer vaccine. Researchers in Israel …

AstraZeneca vaccine linked with ‘spike’ in cases of rare disease that can paralyse victims
1 year, 1 month ago

AstraZeneca vaccine linked with ‘spike’ in cases of rare disease that can paralyse victims

The Telegraph  

Scientists have drawn a link between the Oxford-AstraZeneca vaccine and a “spike” in cases of a rare disease that can leave its victims paralysed. Two of the studies looked at rates of GBS in England and said there was an increase in cases “attributable to” the AstraZeneca vaccine, or that there was a probable “causal link”. ‘Side effects ignored’ Anthony …

A new round of anti-vax misinformation could ruin an otherwise calmer RSV season
1 year, 7 months ago

A new round of anti-vax misinformation could ruin an otherwise calmer RSV season

Salon  

COVID-19 hasn't been the only threat to parents and their children since 2020. "For a long time, we thought of RSV as just being of concern to younger infants and causing mild illness, like colds, in older adults but we're finding that it's not quite as severe as something like influenza, but it causes about a quarter of the deaths …

FDA advisers back RSV vaccine for pregnant women that protects their newborns
1 year, 7 months ago

FDA advisers back RSV vaccine for pregnant women that protects their newborns

Associated Press  

WASHINGTON — A first-of-its-kind RSV vaccine for pregnant women guards their newborns against the scary respiratory virus -– and federal health advisers on Thursday backed Pfizer’s shot despite some lingering questions. In Pfizer’s international study of nearly 7,400 pregnant women, maternal vaccination proved 82% effective at preventing severe RSV during babies’ most vulnerable first three months of life. Earlier this …

US approves 1st vaccine for RSV after decades of attempts
1 year, 8 months ago

US approves 1st vaccine for RSV after decades of attempts

Associated Press  

WASHINGTON — The U.S. approved the first vaccine for RSV on Wednesday, shots to protect older adults against a respiratory virus that’s most notorious for attacking babies but endangers their grandparents, too. to protect older persons from serious RSV disease,” said Dr. William Schaffner, medical director of the National Foundation for Infectious Diseases, who wasn’t involved with its development. There …

FDA panel narrowly backs Pfizer RSV vaccine for older adults
1 year, 10 months ago

FDA panel narrowly backs Pfizer RSV vaccine for older adults

Associated Press  

WASHINGTON — Federal health advisers on Tuesday narrowly backed an experimental vaccine from Pfizer that could soon become the first shot to protect older adults against the respiratory illness known as RSV. The Food and Drug Administration panel voted 7-4 on two separate questions of whether Pfizer’s data showed the vaccine was safe and effective against the respiratory virus for …

New COVID-19 vaccine warnings don’t mean it’s unsafe
3 years, 5 months ago

New COVID-19 vaccine warnings don’t mean it’s unsafe

Salon  

While the COVID-19 vaccines currently available in the U.S. have been proved to be safe and effective, recent reports of rare adverse events, or side effects, have raised concerns. On July 12, 2021, the Food and Drug Administration approved an update to the Johnson & Johnson COVID-19 vaccine fact sheet to include an increased risk of the rare nerve condition …

EXPLAINED: What Is Guillain-Barre Syndrome? Why It's Being Linked To J&J Vaccine
3 years, 5 months ago

EXPLAINED: What Is Guillain-Barre Syndrome? Why It's Being Linked To J&J Vaccine

News 18  

Cases of a rare neurological disorder have emerged in the US among people who were vaccinated with the Covid-19 shot made by Johnson and Johnson, prompting the country’s drug regulator to issue a warning regarding the product. The US Food & Drug Administration has reportedly identified 100 cases of the Guillain-Barre syndrome among people who were vaccinated with the J&J …

FDA adds warning of rare reaction risk to J&J Covid vaccine
3 years, 5 months ago

FDA adds warning of rare reaction risk to J&J Covid vaccine

India TV News  

US regulators on Monday added a new warning to Johnson & Johnson's COVID-19 vaccine about links to a rare and potentially dangerous neurological reaction, but said it's not entirely clear the shot caused the problem. Health officials described the side effect as a “small possible risk" for those getting the shot.\ The action comes after the FDA and the Centers …

Dangerous trend: WHO warns against mixing and matching Covid vaccines
3 years, 5 months ago

Dangerous trend: WHO warns against mixing and matching Covid vaccines

India Today  

The World Health Organisation's chief scientist on Monday advised against people mixing and matching Covid-19 vaccines from different manufacturers, calling it a "dangerous trend" since there was little data available about the health impact. Infectious disease experts are weighing whether people who received Johnson & Johnson's single-dose vaccine should receive a booster of the Pfizer or Moderna mRNA-based vaccine which …

FDA adds warning about rare reaction to Johnson & Johnson COVID-19 vaccine
3 years, 5 months ago

FDA adds warning about rare reaction to Johnson & Johnson COVID-19 vaccine

LA Times  

Vaccines historically provide broad protection with little risk but come with occasional side effects, just like other drugs and medical therapies. U.S. regulators on Monday added a new warning to Johnson & Johnson’s COVID-19 vaccine about links to a rare and potentially dangerous neurological reaction, but said it’s not entirely clear the shot caused the problem. The Food and Drug …

Discover Related